The combined bioinformatics company, which will be called Improved Outcomes Software, will assume the business, personnel, and management teams of both firms. It will also provide software products and services in the bioinformatics, image-guided surgery, and information technology fields, the companies said.
IOS will continue to sell the GeneLinker gene expression analysis software. Predictive Patterns Software was formed last spring to market the GeneLinker software products originally developed by Molecular Mining.
This brief originally appeared in BioInform, GenomeWeb News' sister publication.